Indivior Pharmaceuticals, Inc. (INDV) Stock buybacks 2022–2025
Indivior Pharmaceuticals, Inc. (INDV) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$11.0MFY2025 · since FY2022: $90.0M → $11.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $11.0M | -93.6% |
| FY2024 | $173.0M | +424.2% |
| FY2023 | $33.0M | -63.3% |
| FY2022 | $90.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More INDV financial trends
INDV RevenueINDV Net incomeINDV Net marginINDV Gross profitINDV Gross marginINDV Operating incomeINDV Operating marginINDV Operating cash flowINDV Free cash flowINDV Capital expendituresINDV Return on equityINDV Dividends paidINDV Total assetsINDV Total liabilitiesINDV Shareholders’ equityINDV overview →